PACB R&D Expenses
Pacific Biosciences Of California · R&D Expenses
PACB R&D Expenses
Latest reported$88.36Mperiod ending
PACB TTM R&D Expenses ($111.82M → $88.36M)
TTM R&D Expenses
High-resolution chart · PNG
PACB r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 88,355,000 | |
| 87,862,000 | |
| 97,307,000 | |
| 101,894,000 | |
| 104,564,000 | |
| 120,520,000 | |
| 134,922,000 | |
| 152,000,000 | |
| 173,998,000 | |
| 181,686,000 | |
| 187,170,000 | |
| 185,249,000 | |
| 184,827,000 | |
| 189,002,000 | |
| 193,000,000 | |
| 192,953,000 | |
| 173,369,000 | |
| 145,287,000 | |
| 112,898,000 | |
| 87,747,000 | |
| 76,706,000 | |
| 69,450,000 | |
| 64,152,000 | |
| 61,000,000 | |
| 59,495,000 | |
| 59,395,000 | |
| 59,630,000 | |
| 61,620,000 | |
| 61,014,000 | |
| 61,768,000 | |
| 62,594,000 | |
| 61,957,000 | |
| 63,445,000 | |
| 64,664,000 | |
| 65,324,000 | |
| 65,953,000 | |
| 67,588,000 | |
| 68,227,000 | |
| 67,617,000 | |
| 66,114,000 | |
| 64,797,000 | |
| 62,318,000 | |
| 60,440,000 | |
| 58,019,000 | |
| 53,550,000 | |
| 50,942,000 | |
| 48,230,000 | |
| 47,032,000 | |
| 45,758,000 | |
| 45,005,000 | |
| 45,217,000 | |
| 45,736,000 | |
| 47,943,000 | |
| 47,533,000 | |
| 47,623,000 | |
| 48,386,000 | |
| 55,761,000 | |
| 64,035,000 | |
| 76,080,000 | |
| 90,207,000 | |
| 103,079,000 | |
| 110,615,000 | |
| 111,821,000 | |
| 109,947,000 | |
| 98,195,000 |